Based on 1 Customer Validation
Exatecan mesylate (DX8951f ) GMP is a GMP-class Exatecan (HY-13631). Exatecan is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
For research use only. We do not sell to patients.
- CAS No.: 169869-90-3
- Formula: C25H26FN3O7S
- Molecular Weight:531.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
|
Camptothecins |
Exatecan mesylate is only two-fold resistant to PC-6/SN2-5 (SN-38 resistant cell line)[1].
Exatecan mesylate (10 μM, 30 min) has little difference in the accumulation of PC-6 and PC-6/SN2-5 cells[1].
Exatecan mesylate inhibits tumor growth, with the average GI50 values of 2.02, 2.92, 1.53 and 0.877 ng/mL for breast cancer, colon cancer, gastric cancer, and lung cancer cell lines[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BxPC-3-GFP and MIA-PaCa-2GFP orthotopic implantation mouse model[3]
-
Dosage:15-25 mg/kg; once a week; three weeks
-
Administration:Intravenous injection (i.v.)
-
Result:Significantly inhibited primary tumor growth in MIA-PaCa-2 and BxPC-3, and also significantly reduced lymph node metastasis and completely prevented lung metastasis in the BxPC-3 advanced cancer model.
Chemical Information
-
CAS No. 169869-90-3
-
Appearance Solid
-
Molecular Weight 531.55
-
Formula C25H26FN3O7S
-
Color Light yellow to yellow
-
SMILES
O=S(C)(O)=O.O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C5C6=C(CC[C@@H]5N)C(C)=C(F)C=C6N=C4C3=C2)=O
-
Synonyms
DX8951f (GMP)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (281 KB)
-
SDS (643 KB)
- English - EN (643 KB)
- Français - FR (643 KB)
- Deutsch - DE (643 KB)
- Norwegian - NO (643 KB)
- Español - ES (643 KB)
- Swedish - SV (643 KB)
- Italian - IT (643 KB)
- Korean - KR (643 KB)
- Portuguese - PT (643 KB)
-
Handling Instructions (2659 KB)
References
[1]. Mitsui I, et al. A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo. Jpn J Cancer Res. 1995 Aug;86(8):776-82. [Content Brief]
[2]. Sun FX, et al. Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res. 2003 Jan 1;63(1):80-5. [Content Brief]
[3]. Joto N, et al. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. Int J Cancer. 1997 Aug 7;72(4):680-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)